International Asia director urges use of against fever

WHO director urges use of dengvaxia vaccine against dengue fever

With the alarming rise in dengue cases in the region, the vaccine may be the best solution against prevention though it has its own risk factors




- Advertisement -

It is now 2019, and countries have yet to determine a lasting preventive solution for fever. Just in Singapore alone, more than 2,000 people have caught dengue fever since January this year. This is already more than thrice the number of cases compared to the first quarter of 2018 which had only 600 cases.

Tropical countries in the Southeast Asia and Pacific region are also prone to dengue. Dengue remains endemic in countries such as Singapore, Malaysia, the Philippines, Thailand, and even Hong Kong.

As such, the regional director of the () urged countries to consider implementing the to prevent the spread of the disease.

Dr. Takeshi Kasai, WHO regional director for Western Asia, said that “Dengue is not like in the past when you had a few cases then contained it. It is no longer that kind of disease. Dengue is now with us. It’s like seasonal influenza.”

- Advertisement -

Dr. Kasai made the announcement during a meeting with Hong Kong health officials regarding the alarming rise in dengue cases in the country, as reported by the South China Morning Post.

The US Food and Drug Administration approved the dengvaxia vaccine which aims to prevent the disease in children aged between nine and 16. The vaccine reportedly targets all strains of the tropical virus.

Dengvaxia is developed by Sanofi Pasteur, one the world’s largest multinational pharmaceutical companies.

Health experts warn that the vaccine should only be given to children “who have laboratory-confirmed previous dengue infections and who live in endemic areas.” Before they administer the vaccine, doctors and medical centres must be certain that the patient has had a previous dengue infection.

- Advertisement -

Sanofi discovered that “individuals who have never had a dengue infection before pose a significantly higher risk of a more severe form of the disease and hospitalisations with Dengvaxia than if they had not been vaccinated against dengue at all.”

The vaccine caused a panic and healthcare controversy in the Philippines where school children who were wrongly inoculated allegedly got infected with a strong strain of the virus while a number of children had died. The country has since banned the drug amidst ongoing investigations.

Dengvaxia is approved in 19 countries including Singapore. People interested in getting the vaccine should be aware that it is administered in three parts with six months between  doses./TISG us on Social Media

- Advertisement -

Send in your scoops to 

- Advertisement -

Suspected Ang Mo Kio cat-slasher arrested

Singapore – A 37-year-old man has been arrested for his suspected involvement in a series of cat-slashing incidents in Ang Mo Kio. The Animal & Veterinary Service (AVS), an entity under the National Parks Board (NParks), conducted an operation on Tuesday (June...

Circles.Life telco comes under fire for ad that implies hierarchy between Chinese, Malays and Filipinos; company does not apologise

Update In an update, Circles.Life Singapore issued an apology on their Instagram page on Thursday (Jun 10).   View this post on Instagram   A post shared by Circles.Life (@circleslifesg) Delbert Stanley Ty, Head of Marketing also added: “We messed up. We’re sorry. Our posts were tone...

‘Badge Lady’ asks that charges against her be dropped, claims there were ‘errors’ in the investigation

Singapore — Phoon Chiu Yoke, or "Badge Lady" as she is called by netizens, has been released on S$8,000 bail after she was remanded at the Institute of Mental Health (IMH) for two weeks. The 53-year-old was infamously caught on camera refusing...
Follow us on Social Media

Send in your scoops to